Regenerative Medical Technology RMTG Income Statement (2017-2026)

OTC RMTG
$0.05 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM EDT
Income Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.02M0.17M0.25M0.30M0.30M0.37M0.57M0.79M0.36M0.65M0.62M0.82M0.79M0.99M1.51M1.36M0.98M1.18M1.57M2.64M
Cost of Revenue (Quarter)
0.01M0.09M0.17M0.19M0.15M0.10M0.21M0.25M0.11M0.20M0.18M0.25M0.27M0.24M0.53M0.42M0.40M0.68M0.79M0.87M
Gross Profit (Quarter)
0.00M0.08M0.08M0.11M0.15M0.26M0.36M0.54M0.25M0.45M0.43M0.57M0.53M0.75M0.98M0.94M0.59M0.50M0.78M1.77M
Operating items
Selling, General & Administrative (Quarter)
0.01M0.05M0.08M0.10M0.13M0.11M0.08M0.18M0.23M0.15M0.20M0.16M0.26M0.26M0.11M0.25M0.21M0.28M0.39M0.48M
Other Operating Expenses (Quarter)
0.25M9.04M0.50M0.55M0.38M0.32M2.73M0.43M0.45M0.38M0.37M0.52M0.48M0.46M0.49M0.56M0.63M0.67M0.70M1.06M
Operating Expenses (Quarter)
0.26M9.09M0.58M0.65M0.51M0.43M2.82M0.61M0.68M0.53M0.57M0.67M0.74M0.73M0.60M0.81M0.84M0.95M1.09M1.54M
Operating Income (Quarter)
-0.25M-9.02M-0.50M-0.54M-0.37M-0.16M-2.46M-0.07M-0.43M-0.08M-0.14M-0.11M-0.21M0.02M0.38M0.13M-0.25M-0.45M-0.31M0.23M
EBIT (Quarter)
-0.25M-9.02M-0.50M-0.54M-0.37M-0.16M-2.46M-0.07M-0.43M-0.08M-0.14M-0.11M-0.21M0.02M0.38M0.13M-0.25M-0.45M-0.31M0.23M
Non-operating items
Other Non Operating Income (Quarter)
-0.23M-2.49M0.01M0.00M876.000.00M0.00M998.00964.001.51M-0.00M-708.00-0.00M885.00-0.00M-328.00-865.000.92M1.08M
Non Operating Income (Quarter)
-5.78M-0.12M-1.86M-1.86M-0.91M-1.02M-0.89M-1.06M-3.91M-1.09M-1.11M
Net income details
EBT (Quarter)
-0.69M-9.92M1.16M-1.68M-1.50M-1.34M-2.46M-0.58M-0.43M-1.73M4.72M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M
Profit After Tax (Quarter)
-0.93M-9.92M-1.57M-1.68M-1.49M-1.34M-0.99M-1.67M-2.03M-5.86M-0.26M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-4.35M-1.39M-0.88M
Income from Continuing Operations (Quarter)
-0.69M-9.92M1.16M-1.68M-1.50M-1.34M-2.46M-0.58M-0.43M-1.73M4.72M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M
Consolidated Net Income (Quarter)
-0.69M-9.92M1.16M-124.00208.00-434.000.07M-0.58M-0.43M-1.73M4.72M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M
Income towards Parent Company (Quarter)
-0.69M-9.92M1.16M-124.00208.00-434.000.07M-0.58M-0.43M-1.73M4.72M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M
Net Income towards Common Stockholders (Quarter)
-0.69M-9.92M1.16M-124.00208.00-434.000.07M-0.58M-0.43M-1.73M4.72M-1.96M-2.08M-0.89M-0.64M-0.76M-1.31M-3.94M-2.31M-1.96M
Additional items
EPS (Basic) (Quarter)
-0.06-0.820.100.000.000.000.01-0.05-0.03-0.140.38-0.16-0.17-0.07-0.05-0.06-0.10-0.31-0.18-0.15
EPS (Diluted) (Quarter)
-0.06-0.820.100.000.000.000.01-0.05-0.03-0.140.38-0.16-0.17-0.07-0.05-0.06-0.10-0.31-0.18-0.15
Shares Outstanding (Quarter)
10.93M12.03M11.48M12.09M12.22M12.25M12.22M12.44M12.44M12.44M12.45M12.49M12.49M12.54M12.53M12.54M12.54M12.54M12.63M13.14M
Shares Outstanding (Diluted) (Quarter)
10.93M12.03M11.48M12.09M12.22M12.25M12.22M12.44M12.44M12.44M12.45M12.49M12.49M12.54M12.53M12.54M12.54M12.54M12.63M13.14M
Shares Outstanding (Entity) (Quarter)
12.03M12.03M12.09M12.16M12.25M12.25M12.44M12.44M12.44M12.44M12.49M12.49M12.49M12.54M12.54M12.54M12.54M12.54M13.14M13.14M
EBITDA (Quarter)
-0.25M-9.02M-0.50M-0.54M-0.37M-0.16M-2.46M-0.07M-0.43M-0.08M-0.14M-0.11M-0.21M0.02M0.38M0.13M-0.25M-0.45M-0.31M0.23M
Interest Expenses (Quarter)
0.44M0.90M-1.66M1.14M1.13M1.18M18.000.50M0.00M1.66M-4.86M1.85M1.86M0.91M1.02M0.90M1.06M3.49M2.01M2.19M